Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Richman

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trialsJ F Seligmann, D Fisher, C G Smith, et al.
West African Journal of Medicine|January 12, 2013
KRAS and BRAF mutations in Nigerian colorectal cancersF B Abdulkareem, L A Sanni, S D Richman, et al.
Virchows Archiv : an International Journal of Pathology|December 18, 2012
KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assuranceJ R Dijkstra, D A M Heideman, G A Meijer, et al.
British Journal of Cancer|April 19, 2014
A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?T S Maughan, A M Meade, R A Adams, et al.
ESMO Open|March 5, 2022
Artificial intelligence for detection of microsatellite instability in colorectal cancer-a multicentric analysis of a pre-screening tool for clinical applicationA Echle, N Ghaffari Laleh, P Quirke, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trialsJ F Seligmann, D Fisher, C G Smith, et al.
West African Journal of Medicine|January 12, 2013
KRAS and BRAF mutations in Nigerian colorectal cancersF B Abdulkareem, L A Sanni, S D Richman, et al.
Virchows Archiv : an International Journal of Pathology|December 18, 2012
KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assuranceJ R Dijkstra, D A M Heideman, G A Meijer, et al.
British Journal of Cancer|April 19, 2014
A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?T S Maughan, A M Meade, R A Adams, et al.
ESMO Open|March 5, 2022
Artificial intelligence for detection of microsatellite instability in colorectal cancer-a multicentric analysis of a pre-screening tool for clinical applicationA Echle, N Ghaffari Laleh, P Quirke, et al.
Pageof 2